Targeting bromodomain and extra-terminal proteins to inhibit neuroblastoma tumorigenesis through regulating MYCN.

导出 LinkOut

翻译打印收藏纠错

作者： Xiyao,Shi ^[1] ; Ying,Wang ^[2] ; Longhui,Zhang ^[3] ; Wenjie,Zhao ^[1] ; Xiangpeng,Dai ^[2] ; Yong-Guang,Yang ^[1] ; Xiaoling,Zhang ^[2]

作者单位： Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, First Hospital, Jilin University, Changchun, China. ^[1] National-Local Joint Engineering Laboratory of Animal Models for Human Disease, First Hospital, Jilin University, Changchun, China. ^[2] Department of Laboratory Medicine, First Hospital, Jilin University, Changchun, China. ^[3] International Center of Future Science, Jilin University, Changchun, China. ^[4]

关键词 BET family proteins BRD4 inhibitors MYCN epigenetic regulation neuroblastoma

DOI 10.3389/fcell.2022.1021820

PMID 36187481

发布时间 2022-10-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in cell and developmental biology

2022年10卷

1021820页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Targeting bromodomain and extra-terminal proteins to inhibit neuroblastoma tumorigenesis through regulating MYCN.

Frontiers in cell and developmental biology

相似文献

Frontiers in cell and developmental biology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Targeting bromodomain and extra-terminal proteins to inhibit neuroblastoma tumorigenesis through regulating MYCN.

Frontiers in cell and developmental biology

相似文献

Frontiers in cell and developmental biology

相关期刊

检索历史清除